Shares in medical device and neurotech company Helius Medical Technologies dropped 16% on Monday amid news that the firm made its first Solana treasury acquisition.  Helius added 760,190 SOL at an average purchase price of $231, valuing its treasury at around $168 million. It still maintains around $335 million in cash which will help propel further additions to its Solana treasury.  “It has been gratifying to receive shows of support from multiple stakeholders across the Solana ecosystem, including staking ...